ClinicalTrials.Veeva

Menu
Y

York Clinical Research, LLC | Norfolk, VA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Empagliflozin
Olezarsen
Triglyceride
IONIS-AGT-LRx
ISIS 678354
PF-08653944
K-877
ARO-APOC3
LY3841136

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 44 total trials

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk (ENLIGHTEN-10)

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with a placebo in participants with obesity or overwei...

Begins enrollment this month
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost w...

Enrolling
Overweight and/or Obesity
Overweight
Drug: Berobenatide
Drug: Semaglutide

The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or ob...

Enrolling
Overweight and/or Obesity
Overweight
Drug: PF-08653944
Other: Placebo

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Placebo
Drug: Muvalaplin

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.

Active, not recruiting
Severe Hypertriglyceridemia
Drug: Olezarsen

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Active, not recruiting
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular...

Active, not recruiting
Cardiovascular Disease
Drug: Cagrilintide
Drug: Semaglutide

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Novo Nordisk logo
Ionis Pharmaceuticals logo
Boehringer Ingelheim logo
Novartis logo
Amgen logo
Kowa logo
Lilly logo
Pfizer logo
A
Arrowhead Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems